C

Chimerix
D

CMRX

0.90210
USD
0.00
(0.23%)
مغلق
حجم التداول
4,830
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
81,131,313
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    D
    DVAX
    -1.180
    (-8.81%)
    12.210 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    I
    INO
    -0.54000
    (-11.25%)
    4.26000 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.830 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    المزيد
الأخبار

العنوان: Chimerix

القطاع: Healthcare
الصناعة: Biotechnology
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.